By Stephen Morris in Davos, Hannah Kuchler, Madhumita Murgia in London
The San Francisco-based start-up plans to get its first drug into trials this year
https://www.ft.com/content/25a473ea-9f87-474a-8729-bc5287df853a
Posted inArtificial Intelligence Financial Times
[FT]: Sam Altman-backed Retro Biosciences to raise $1bn for project to extend human life.
